Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

MDxHealth (MDXH) Accumulated Depreciation & Amortization (2020 - 2025)

MDxHealth has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $8.2 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 13.75% year-over-year to $8.2 million; the TTM value through Dec 2025 reached $8.2 million, up 13.75%, while the annual FY2025 figure was $8.2 million, 13.75% up from the prior year.
  • Accumulated Depreciation & Amortization was $8.2 million for Q4 2025 at MDxHealth, up from $7.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $8.4 million in Q4 2023 and bottomed at $6.2 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $7.2 million (2024), against an average of $7.3 million.
  • Year-over-year, Accumulated Depreciation & Amortization rose 25.56% in 2023 and then fell 14.5% in 2024.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $6.2 million in 2021, then rose by 7.97% to $6.7 million in 2022, then grew by 25.56% to $8.4 million in 2023, then fell by 14.5% to $7.2 million in 2024, then increased by 13.75% to $8.2 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $8.2 million (Q4 2025), $7.2 million (Q4 2024), and $8.4 million (Q4 2023) per Business Quant data.